Persistent exhaustion, shortness of breath, leg swelling, confusion

Heart failure, sometimes called congestive heart failure or CHF, is a condition in which your heart slowly weakens and loses its ability to pump enough oxygen-rich blood to the body. It is a chronic, progressive disease, which means there is no cure.

About half of heart failure patients have a reduced ejection fraction and an enlarged left ventricle (the main pumping chamber of the heart).  This causes more stress on the heart and leads to reduced pumping efficiency and heart failure symptoms.


After a diagnosis of heart failure, your physician may prescribe medications to help treat symptoms and provide guidance on important lifestyle modifications, such as making changes to your diet and increasing the amount of exercise you do. In some cases, you may also be prescribed an implantable pacemaker, or cardiac resynchronization therapy device, to help manage symptoms and improve heart function.

However, when your condition eventually progresses beyond the ability of medications or pacemakers to manage symptoms, often the only options left include implantation of a left ventricular assist device (LVAD) or a heart transplant.


The AccuCinch Ventricular Restoration System is a new, minimally invasive therapy for the millions of patients who suffer from heart failure with reduced ejection fraction.

It was designed to treat the left ventricle, the main pumping chamber of the heart, which when enlarged, causes heart failure symptoms and can lead to disease progression.

If you are a patient with heart failure that has progressed beyond the ability of medications and pacemakers to manage symptoms, the AccuCinch System may be a new treatment option to consider.

The AccuCinch Ventricular Restoration System has been granted Breakthrough Device Designation by the FDA, a program designation for certain medical devices that may provide for more effective treatment options for patients with life-threatening or irreversibly debilitating diseases or conditions.  Learn more about the FDA Breakthrough Devices Program here.

CAUTION – Investigational device.  Limited by United States law to investigational use.


During a minimally invasive, catheter-based procedure, a flexible implant is attached to the inner wall of your heart’s left ventricle and then cinched. The implant is intended to reduce the size of your left ventricle and support and strengthen the wall of your heart.

As a complement to existing care, the AccuCinch System is a new approach to heart failure therapy that may help reduce symptoms, improve quality of life and potentially increase life expectancy.

Click links to play in additional languages: French, Lithuanian, Dutch, German, Italian, Spanish.

AccuCinch Patient Story: Edward Ward

Edward Ward participated in a clinical trial evaluating the AccuCinch Ventricular Restoration System. Watch the video to learn more about his experience with AccuCinch.


Ancora Heart is currently enrolling patients in the CORCINCH-HF Study, a prospective, randomized, open-label, multicenter, international, clinical safety and efficacy investigation of the AccuCinch System in symptomatic heart failure patients with reduced ejection fraction (HFrEF).

Enrolled patients will receive treatment with the AccuCinch System and guideline-directed medical therapy (GDMT) or GDMT alone.

Are you a candidate for the CORCINCH-HF Study?

  • Have you been told you have heart failure?
  • Has your doctor explained that you have reduced ejection fraction?
  • Are you taking heart failure medications, but your symptoms are worsening (e.g., shortness of breath, fatigue, coughing, leg swelling, or trouble breathing at night)?

If you have been diagnosed with heart failure and answered “yes” to any of the questions above, you may be eligible to participate. Talk to your physician or click the links below to learn more.

To Learn More